Plug and play nanocage assembly for antiviral prevention

This project showcases the development of novel antiviral nanocage devices for rapid response to viral infections.
Using our "plug-and-play" nanocage assembly technology, we engineer pre-approved building blocks whose designs can be accelerated by AI to rapidly assemble ready-to-go, broad-spectrum antiviral nanocages that bind to viruses and neutralize them. At the same time, the nanocages carry antiviral drug cargo that will be delivered by the virus-nanocage complex to the site of infection for targeted delivery and prevention of viral replication.